What happens when immune cells just won't die?

Sep 14, 2009

X-linked lymphoproliferative disease (XLP) is a rare inherited immunodeficiency most commonly caused by deficiency in the protein SAP.

Following infection with the common virus that causes infectious mononucleosis (also known as mono or glandular fever), boys with XLP often develop an extreme, usually fatal, accumulation of activated immune cells known as cytotoxic T lymphocytes; but the mechanistic link between this and SAP deficiency has not been determined.

However, Michael Lenardo and colleagues, at the NIH, Bethesda, have now found that from individuals with XLP are resistant to cell death triggered by repeated stimulation of a cell surface protein complex known as the TCR.

As repeated TCR stimulation normally constrains T cell expansion during immune responses, the authors propose that this makes the T susceptible to uncontrolled expansion upon infection.

More information: View the PDF of this article at: www.the-jci.org/article.php?id=39518

Source: Journal of Clinical Investigation

Explore further: Scientists find new calorie-burning switch in brown fat

add to favorites email to friend print save as pdf

Related Stories

Scientists discover crucial control in long-lasting immunity

Oct 10, 2008

National Institutes of Health (NIH) scientists have identified a protein that plays matchmaker between two key types of white blood cells, T and B cells, enabling them to interact in a way that is crucial to establishing ...

How STDs increase the risk of becoming infected with HIV

Sep 05, 2008

Individuals who have a sexually transmitted disease (e.g., genital herpes, gonorrhea, syphilis, and chlamydia) and women with yeast and bacterial vaginal infections have an increased risk of becoming infected with HIV if ...

Vaccine shows promise in preventing mono

Dec 10, 2007

A new study suggests that a vaccine targeting Epstein-Barr virus (EBV) may prevent infectious mononucleosis, commonly known as “mono” or “glandular fever.” The study is published in the December 15 issue of The Jo ...

How mice and humans differ immunologically

Aug 10, 2009

Edith Hessel and colleagues, at Dynavax Technologies Corporation, Berkeley, have identified the reason that humans and rodents respond differently to a molecule that is being developed to treat allergic diseases.

Anti-HIV drugs reduce the cause of some forms of vision loss

May 23, 2008

A potential new therapeutic use for anti-HIV drugs known as protease inhibitors has been suggested by a team of researchers from Harvard Medical School, Boston, and Inserm U848, France, as a result of their work in a mouse ...

Recommended for you

Small RNAs in blood may reveal heart injury

3 hours ago

(Medical Xpress)—Like clues to a crime, specific molecules in the body can hint at exposure to toxins, infectious agents or even trauma, and so help doctors determine whether and how to treat a patient. ...

Researchers uncover clues to flu's mechanisms

7 hours ago

A flu virus acts like a Trojan horse as it attacks and infects host cells. Scientists at Rice University and Baylor College of Medicine have acquired a clearer view of the well-hidden mechanism involved.

User comments : 0